148 related articles for article (PubMed ID: 27020572)
41. Intrahost evolution of envelope glycoprotein and OrfA sequences after experimental infection of cats with a molecular clone and a biological isolate of feline immunodeficiency virus.
Huisman W; Schrauwen EJ; Rimmelzwaan GF; Osterhaus AD
Virus Res; 2008 Oct; 137(1):24-32. PubMed ID: 18602181
[TBL] [Abstract][Full Text] [Related]
42. Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors.
Giannecchini S; Pistello M; Del Santo B; Rovero P; Sichi O; Bendinelli M
New Microbiol; 2004 Apr; 27(2 Suppl 1):77-84. PubMed ID: 15646068
[TBL] [Abstract][Full Text] [Related]
43. Ramified feline microglia selects for distinct variants of feline immunodeficiency virus during early central nervous system infection.
Hein A; Schuh H; Thiel S; Martin JP; Dörries R
J Neurovirol; 2003 Aug; 9(4):465-76. PubMed ID: 12907391
[TBL] [Abstract][Full Text] [Related]
44. Localisation of three epitopes of the env protein of feline immunodeficiency virus.
Avrameas A; Guillet JG; Chouchane L; Moraillon A; Sonigo P; Strosberg AD
Mol Immunol; 1992 May; 29(5):565-72. PubMed ID: 1374840
[TBL] [Abstract][Full Text] [Related]
45. Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.
Pancino G; Camoin L; Sonigo P
J Virol; 1995 Apr; 69(4):2110-8. PubMed ID: 7884857
[TBL] [Abstract][Full Text] [Related]
46. Removal of the cleavage site of recombinant feline immunodeficiency virus envelope protein facilitates incorporation of the surface glycoprotein in immune-stimulating complexes.
Rimmelzwaan GF; Siebelink KH; Huisman RC; Moss B; Francis MJ; Osterhaus AD
J Gen Virol; 1994 Aug; 75 ( Pt 8)():2097-102. PubMed ID: 8046415
[TBL] [Abstract][Full Text] [Related]
47. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
Mealey RH; Leib SR; Pownder SL; McGuire TC
J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
[TBL] [Abstract][Full Text] [Related]
48. Identification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.
Pikora C; Wittish C; Desrosiers RC
J Virol; 2005 Oct; 79(19):12575-83. PubMed ID: 16160185
[TBL] [Abstract][Full Text] [Related]
49. Upregulation of surface feline CXCR4 expression following ectopic expression of CCR5: implications for studies of the cell tropism of feline immunodeficiency virus.
Willett BJ; Cannon CA; Hosie MJ
J Virol; 2002 Sep; 76(18):9242-52. PubMed ID: 12186908
[TBL] [Abstract][Full Text] [Related]
50. The role of the chemokine receptor CXCR4 in infection with feline immunodeficiency virus.
Willett BJ; Hosie MJ
Mol Membr Biol; 1999; 16(1):67-72. PubMed ID: 10332739
[TBL] [Abstract][Full Text] [Related]
51. A tyrosine motif in the cytoplasmic domain of mason-pfizer monkey virus is essential for the incorporation of glycoprotein into virions.
Song C; Dubay SR; Hunter E
J Virol; 2003 May; 77(9):5192-200. PubMed ID: 12692221
[TBL] [Abstract][Full Text] [Related]
52. The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry.
Giannecchini S; Bonci F; Pistello M; Matteucci D; Sichi O; Rovero P; Bendinelli M
Virology; 2004 Mar; 320(1):156-66. PubMed ID: 15003871
[TBL] [Abstract][Full Text] [Related]
53. Emergence of CD134 cysteine-rich domain 2 (CRD2)-independent strains of feline immunodeficiency virus (FIV) is associated with disease progression in naturally infected cats.
Bęczkowski PM; Techakriengkrai N; Logan N; McMonagle E; Litster A; Willett BJ; Hosie MJ
Retrovirology; 2014 Nov; 11():95. PubMed ID: 25430586
[TBL] [Abstract][Full Text] [Related]
54. Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection.
Willett BJ; Hosie MJ
Vet Immunol Immunopathol; 2008 May; 123(1-2):56-64. PubMed ID: 18289703
[TBL] [Abstract][Full Text] [Related]
55. Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1.
Sato E; Yokoyama N; Miyazawa T; Maeda K; Ikeda Y; Nishimura Y; Fujita K; Kohmoto M; Takahashi E; Mikami T
Virus Res; 2000 Sep; 70(1-2):13-23. PubMed ID: 11074121
[TBL] [Abstract][Full Text] [Related]
56. Neurotoxic effects of feline immunodeficiency virus, FIV-PPR.
Gruol DL; Yu N; Parsons KL; Billaud JN; Elder JH; Phillips TR
J Neurovirol; 1998 Aug; 4(4):415-25. PubMed ID: 9718133
[TBL] [Abstract][Full Text] [Related]
57. Expression of CXCR4 in the brain of feline immunodeficiency virus infected cat.
Koirala TR; Sharma S; Morikawa S; Ishida T
Indian J Pathol Microbiol; 2000 Jul; 43(3):285-90. PubMed ID: 11218674
[TBL] [Abstract][Full Text] [Related]
58. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain.
Ritter GD; Mulligan MJ; Lydy SL; Compans RW
Virology; 1993 Nov; 197(1):255-64. PubMed ID: 8212561
[TBL] [Abstract][Full Text] [Related]
59. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
60. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain.
Duda A; Lüftenegger D; Pietschmann T; Lindemann D
J Virol; 2006 Aug; 80(16):8158-67. PubMed ID: 16873272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
